COMMUNIQUÉS West-GlobeNewswire

Communiqué : Essilor met son expertise de l'économie inclusive au service de la santé visuelle dans le Commonwealth
16/04/2018
Essilor met son expertise de l'économie inclusive au service de la santé visuelle dans le Commonwealth Version PDF du communiqué (Charenton-le-Pont, France, 16 avril 2018) - Essilor s'engage à étendre ses modèles d' [...]
Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck
16/04/2018
BERKELEY, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced data from its ongoing Phase 1b/2 study investigating SD-101, Dynavax's intratumoral TLR9 agonist, in [...]
Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy
16/04/2018
Heidelberg, Germany, April 16, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today presented a poster [...]
Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data at American Association for Cancer Research (AACR) Annual Meeting
16/04/2018
- Preclinical testing raises no safety concerns for MAGE A4 - - Refined preclinical testing strategy expected to further mitigate risk of unexpected off-target toxicity - PHILADELPHIA, Pa. and OXFORD, United Kingdom, [...]
Atlanta City Council issues Sharecare Day proclamation at inaugural Sharecare Heartbeat Festival
16/04/2018
NBA jersey patch partner and Atlanta Hawks bring 3-v-3 Basketball tournament back to the city as part of Sharecare’s first community celebration in Atlanta ATLANTA, April 16, 2018 (GLOBE NEWSWIRE) -- During the [...]
Tauriga Sciences Inc. Formally Cancels All Remaining Back-End Convertible Debentures Held by Adar Bays LLC in Connection with the $210,000 Financing Agreement from September 2017
16/04/2018
NEW YORK, NY, April 16, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]
Ossur Hf : Transactions in relation to share buyback program
16/04/2018
Announcement no. 29/2018 Reykjavik, 16 April 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
16/04/2018
FIT Biotech Oy Company release April 16, 2018 at 6:30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]
Sienna Announces Q1 2018 Results Release Date and Conference Call
16/04/2018
MARKHAM, Ontario, April 16, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA ) announced that it will report its 2018 first quarter results after market close on Thursday, May [...]
Addus HomeCare Announces First-Quarter 2018 Earnings Release and Conference Call
16/04/2018
Frisco, Texas, April 16, 2018 (GLOBE NEWSWIRE) -- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of comprehensive home care services, announced today that it will release earnings for the first quarter ended [...]
Innovation Pharmaceuticals Data from Phase 2 Brilacidin Oral Mucositis (OM) Trial in Head and Neck Cancer Show Notable Reductions in Median Duration of Severe OM and in Number of Unplanned Visits/Hospital Admissions Due to OM
16/04/2018
Median Duration of Severe Oral Mucositis (SOM) Reduced to Less Than One Day No Unplanned Office Visits, Emergency Department Visits, and/or Hospital Admissions Due to OM in Brilacidin-OM Arm vs. Four in Placebo Arm Data [...]
California Proposes Bills to Outlaw Self-Determination in Medical Therapy, Reports the Association of American Physicians and Surgeons (AAPS)
16/04/2018
TUCSON, Ariz., April 16, 2018 (GLOBE NEWSWIRE) -- Three bills moving rapidly through the California legislature threaten to outlaw certain treatments that may be offered by physicians or other therapists, or sought by [...]
Nelipak Healthcare Packaging Announces Freestanding Rotary Medical Tray and Blister Heat Sealers
16/04/2018
Machine Portfolio Also Includes Enhanced PLC Controlled and Analog Sealers CRANSTON, R.I., April 16, 2018 (GLOBE NEWSWIRE) -- Nelipak ® Healthcare Packaging (“Nelipak”), a full-service global provider of custom [...]
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
16/04/2018
SALT LAKE CITY, April 16, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]
Photocure ASA: Annual accounts 2017
16/04/2018
Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017. The annual accounts and annual report for the financial year 2017 are enclosed with this [...]
Photocure ASA: Notice of the annual general meeting 9 May 2018
16/04/2018
Oslo, 16 April 2018: Photocure ASA (OSE: PHO), calls for the annual general meeting of PHO to be held at Hoffsveien 4, 1 st floor, 0275 Oslo, Norway on 9 May 2018 at 17:00 hours (CET). The notice convening the general [...]
Apellis Pharmaceuticals Provides Update on Phase 1b Open Label Study of APL-2 in PNH Patients Not Previously Treated with Eculizumab
16/04/2018
Interim data shows broad hematologic correction including improved hemoglobin levels and reduction in LDH CRESTWOOD, Ky. and WALTHAM, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS [...]
Novo Nordisk A/S - Share repurchase programme
16/04/2018
Bagsværd, Denmark, 16 April 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform
16/04/2018
Preclinical Data Presented at AACR Highlight the Novel Mechanism of Action Underscoring the Company’s T cell-Activating Technology HALIFAX, Nova Scotia, April 16, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV [...]

Pages